Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
251 Product characterization of a clinical-grade BCMA CAR-MIL therapy supports IND-enabling development for multiple myeloma
5 affiliations
- 1Vaxcellbio CO., LTD., Hwasun, Jeollanamdo, Republic of Korea
- 2Aff2 0000 0004 0647 9534grid.411602.0Hematology-OncologyChonnam National University Hwasun Hospital 58128 Hwasun-gun Jeollanam-do South Korea
- 3Hallym University Dongtan Sacred Heart Hospital, Republic of Korea
- 41Vaxcell-bio CO., LTD., Hwasun-gun, Jellanamdo, Republic of Korea
- 5College of Nursing, Seoul National University, Seoul, Korea (the Republic of)
Related
- CLINICAL CHARACTERIZATION OF AN EINSTEIN HOSPITAL BIOBANK DERIVED COHORT FOR INTEGRATED MULTI-OMICS ANALYSIS IN PATIENTS WITH MULTIPLE MYELOMA
- CO082 | IN SILICO ANALYSIS THROUGH A NEW-GENERATED FACTOR VIII MODEL SUPPORTS TOLERANCE OF B DOMAIN TO MULTIPLE AMINO ACID SUBSTITUTIONS, LIMITING THE LOCAL IMPACT OF MISSENSE VARIANTS
- Arginine Kinase 1 supports energy homeostasis in Drosophila flight muscle development
- Genomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones
- Photographic Atlas for Cosmetic Noodling Characterization: Development, Analytical Validation, and Consumer Perception
BibTeX
@article{vo2026product,
title = {{251 Product characterization of a clinical-grade BCMA CAR-MIL therapy supports IND-enabling development for multiple myeloma}},
author = {Manh-Cuong Vo and Je-Jung Lee and Bomi Park and Sang-ki Kim and Yu-Jin Park and Minwoo Baek and Seung joo Yang},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0251},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0251},
note = {CC BY},
}
RIS
TY - JOUR
TI - 251 Product characterization of a clinical-grade BCMA CAR-MIL therapy supports IND-enabling development for multiple myeloma
AU - Manh-Cuong Vo
AU - Je-Jung Lee
AU - Bomi Park
AU - Sang-ki Kim
AU - Yu-Jin Park
AU - Minwoo Baek
AU - Seung joo Yang
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0251
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0251
SN - 2051-1426
ER -